Paykel-backed NZ serum exporter snaps up Aussie rival

Paykel-backed NZ serum exporter snaps up Aussie rival
Acquiring CellSera adds a 'critical new serum' to the Auckland firm’s existing product range. (Photo: supplied)
Dan Brunskill
Animal serum and plasma exporter Auckland BioSciences (ABS) has purchased an Australian competitor as it seeks to become a global industry leader.The company manufactures and exports premium New Zealand-made animal-derived serum and plasma, which are key ingredients for growing cells for bio-pharmaceutical manufacturing and medical research. While it’s not a glamourous export, this serum is vital to biotech research and the production of vaccines – including some for covid-19.“While our business is operationally complex,...

More Markets

NZ sharemarket up 0.3% after three falls
Markets Market close

NZ sharemarket up 0.3% after three falls

The S&P/NZX 50 Index closed at 12,761.35, gaining 37.98 points or 0.3%.

Graham Skellern 11 Dec 2024
Winton 'stands to gain millions': MP
Property

Winton 'stands to gain millions': MP

The proposed fast-tracking of Sunfield is 'cronyism', local MP claims.

Maria Slade 11 Dec 2024
ForBarr raises Hallenstein Glasson target price 20%
Retail

ForBarr raises Hallenstein Glasson target price 20%

The outlook in the golden country is golden, they say.

Gregor Thompson 11 Dec 2024